About
Company Overview
Our Vision
Corporate Structure
Corporate Governance
Board of Directors
Remuneration Committee
Organization and Operation of Internal Audit
Corporate Governance Status
Corporate Regulations
Corporate Social Responsibility Status
Management
Careers
Subsidiaries
Medigen Vaccine Biologics Corporation
TBG Diagnostics Limited
Winston Medical & Biotech Group
Cell Therapy
MAGICELLl–NK (Natural killer cells)
MAGICELL®-GDT(T cells)
GTP certificated cell processing facility
Cell Therapy Cooperation Agency
Cell Therapy Regulation in Taiwan
COVID-19
CLINICAL TRIALS
NK CELL (MAGICELL-NK)
OBP-301 (Telomelysin)
NEWS
Material Information
2024
2023
2021
Financial Statement
Shareholder Services
Investors
Financial Statements
Monthly Revenue Statement
Quarterly and Annual Report
Shareholder Services
Share Price
Shareholder Meeting Document
Contact Information
Stakeholders
Language
中文 (繁)
English
中文 (简)
MAGICELL®-GDT(T Cells)
Home
|
Cell Therapy Technology
|
MAGICELL®-GDT(T Cells)
GDT Cells (Gamma-delta T Cells)
MEDINET (MEDINET Co., Ltd.)
Clinical Studies Published Literature
![Medigen-GDT-TW-V210-sub-1080p.mp4_20201113_112559.567[870x320]](http://www.medigen.com.tw/wp-content/uploads/2020/01/Medigen-GDT-TW-V210-sub-1080p.mp4_20201113_112559.567870x320.jpg)
![Medigen-GDT-TW-V210-sub-1080p.mp4_20201113_112625.558[870x320]](http://www.medigen.com.tw/wp-content/uploads/2020/01/Medigen-GDT-TW-V210-sub-1080p.mp4_20201113_112625.558870x320.jpg)
![2019企業影片_英文無字幕.mp4_000130.125[870x320]](http://www.medigen.com.tw/wp-content/uploads/2020/01/2019企業影片_英文無字幕.mp4_000130.125870x320.png)